- Home
- OKYO vs CNVS Comparison
OKYO vs CNVS Comparison
Compare OKYO & CNVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OKYO
- CNVS
- Stock Information
- Founded
- OKYO 2007
- CNVS 2000
- Country
- OKYO United Kingdom
- CNVS United States
- Employees
- OKYO N/A
- CNVS N/A
- Industry
- OKYO Biotechnology: Biological Products (No Diagnostic Substances)
- CNVS Consumer Electronics/Video Chains
- Sector
- OKYO Health Care
- CNVS Consumer Discretionary
- Exchange
- OKYO Nasdaq
- CNVS Nasdaq
- Market Cap
- OKYO 77.9M
- CNVS 64.1M
- IPO Year
- OKYO 2022
- CNVS 2003
- Fundamental
- Price
- OKYO $2.55
- CNVS $3.05
- Analyst Decision
- OKYO Strong Buy
- CNVS Buy
- Analyst Count
- OKYO 1
- CNVS 2
- Target Price
- OKYO $7.00
- CNVS $9.50
- AVG Volume (30 Days)
- OKYO 197.8K
- CNVS 104.7K
- Earning Date
- OKYO 07-18-2025
- CNVS 11-13-2025
- Dividend Yield
- OKYO N/A
- CNVS N/A
- EPS Growth
- OKYO N/A
- CNVS N/A
- EPS
- OKYO N/A
- CNVS 0.13
- Revenue
- OKYO N/A
- CNVS $80,173,000.00
- Revenue This Year
- OKYO N/A
- CNVS $0.76
- Revenue Next Year
- OKYO N/A
- CNVS N/A
- P/E Ratio
- OKYO N/A
- CNVS $23.14
- Revenue Growth
- OKYO N/A
- CNVS 77.07
- 52 Week Low
- OKYO $0.90
- CNVS $2.13
- 52 Week High
- OKYO $3.35
- CNVS $7.39
- Technical
- Relative Strength Index (RSI)
- OKYO 64.07
- CNVS 35.75
- Support Level
- OKYO $2.11
- CNVS $3.09
- Resistance Level
- OKYO $2.70
- CNVS $3.31
- Average True Range (ATR)
- OKYO 0.17
- CNVS 0.15
- MACD
- OKYO 0.07
- CNVS 0.04
- Stochastic Oscillator
- OKYO 89.95
- CNVS 12.12
About OKYO OKYO Pharma Limited
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.
About CNVS Cineverse Corp.
Cineverse Corp is a main streaming technology and entertainment company. Its core business operates as a portfolio of owned and operated streaming channels with enthusiast fan bases; a large-scale aggregator and full-service distributor of feature films and television programs; and a proprietary technology software-as-a-service platform for over-the-top (OTT) app development and content distribution through subscription video-on-demand (SVOD), dedicated ad-supported (AVOD), ad-supported streaming linear (FAST) channels, social video streaming services, and audio podcasts. It generates revenue from streaming and digital, Base distribution, Podcast and other, and Other non-recurring.